141 related articles for article (PubMed ID: 3436115)
1. Vitamin C metabolites and microangiopathy in diabetes mellitus.
Jennings PE; Chirico S; Jones AF; Lunec J; Barnett AH
Diabetes Res; 1987 Nov; 6(3):151-4. PubMed ID: 3436115
[TBL] [Abstract][Full Text] [Related]
2. Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes.
Lindsay RM; Jamieson NS; Walker SA; McGuigan CC; Smith W; Baird JD
Diabetologia; 1998 May; 41(5):516-23. PubMed ID: 9628267
[TBL] [Abstract][Full Text] [Related]
3. Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation.
Sinclair AJ; Girling AJ; Gray L; Le Guen C; Lunec J; Barnett AH
Diabetologia; 1991 Mar; 34(3):171-5. PubMed ID: 1884888
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
5. Role of plasma ascorbate in diabetic microangiopathy.
Ali SM; Chakraborty SK
Bangladesh Med Res Counc Bull; 1989 Dec; 15(2):47-59. PubMed ID: 2629696
[TBL] [Abstract][Full Text] [Related]
6. [The effect of diabetic compensation on plasma levels of dehydroascorbic acid in insulin-dependent diabetics].
Kábrt J; Kramlová J; Skrha J
Cas Lek Cesk; 1987 Nov; 126(46):1430-2. PubMed ID: 3690619
[No Abstract] [Full Text] [Related]
7. Blood vitamin C concentrations in patients with diabetes mellitus.
Schorah CJ; Bishop N; Wales JK; Hansbro PM; Habibzadeh N
Int J Vitam Nutr Res; 1988; 58(3):312-8. PubMed ID: 3198319
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between concentration of growth hormone in serum and microangiopathy in patients with diabetes mellitus].
Chen M; Yu W; Hu S
Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):765-7. PubMed ID: 9772523
[TBL] [Abstract][Full Text] [Related]
9. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
[TBL] [Abstract][Full Text] [Related]
10. Serum antioxidant activity in diabetes mellitus.
Jones AF; Winkles JW; Jennings PE; Florkowski CM; Lunec J; Barnett AH
Diabetes Res; 1988 Feb; 7(2):89-92. PubMed ID: 3396268
[TBL] [Abstract][Full Text] [Related]
11. Rheological changes in diabetic microangiopathy.
Negrean V; Suciu I; Sâmpelean D; Cozma A
Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
[TBL] [Abstract][Full Text] [Related]
13. Uptake mechanisms for ascorbate and dehydroascorbate in lymphoblasts from diabetic nephropathy and hypertensive patients.
Ng LL; Ngkeekwong FC; Quinn PA; Davies JE
Diabetologia; 1998 Apr; 41(4):435-42. PubMed ID: 9562348
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of various hemorheologic parameters in diabetes mellitus].
Cella A; Bianchi E; Reali GL; Piana A; Armani U
Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
[TBL] [Abstract][Full Text] [Related]
15. Increased glutathionylated hemoglobin (HbSSG) in type 2 diabetes subjects with microangiopathy.
Sampathkumar R; Balasubramanyam M; Sudarslal S; Rema M; Mohan V; Balaram P
Clin Biochem; 2005 Oct; 38(10):892-9. PubMed ID: 16051210
[TBL] [Abstract][Full Text] [Related]
16. [Modification of hemorheological parameters in microvascular complications of diabetes].
Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
[TBL] [Abstract][Full Text] [Related]
17. [Prostacyclin-like activity modifying plasma factors in diabetic microangiopathy].
Magyari M; Túri S; Csanálosi-Németh M
Fortschr Ophthalmol; 1990; 87(3):269-73. PubMed ID: 2115854
[TBL] [Abstract][Full Text] [Related]
18. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.
Lodovici M; Giovannelli L; Pitozzi V; Bigagli E; Bardini G; Rotella CM
Mutat Res; 2008 Feb; 638(1-2):98-102. PubMed ID: 17964614
[TBL] [Abstract][Full Text] [Related]
19. Relationship of oxidative stress and fibrinolysis in diabetes mellitus.
Skrha J; Hodinár A; Kvasnicka J; Hilgertová J
Diabet Med; 1996 Sep; 13(9):800-5. PubMed ID: 8891455
[TBL] [Abstract][Full Text] [Related]
20. Plasma fibronectin in diabetic retinopathy and macroangiopathy.
Seghieri G; Bartolomei G; De Giorgio LA
Diabete Metab; 1986 Aug; 12(4):186-90. PubMed ID: 3770274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
